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In most epidemiological reviews, ovarian cancer is
considered as one disease, although some recent ones have
categorised the cases as epithelial and non-epithelial
(Newhouse et al., 1977; Greene et al., 1984). But within
those of epithelial origin, different pathological diagnoses
can also be analysed separately.
Several risk factors, such as age at birth of first child, age
at menopause, number of pregnancies, smoking habits and
history of previous viral diseases, such as mumps, measles
and chicken pox, have been associated with ovarian
cancer. But none of them have been related to specific
histological type. Non-contraceptive oestrogens have been
associated with increased risk of endometrioid tumours
(Weiss et al., 1982). The reduction in risk by oral
contraceptives was similar in four histological subtypes of
epithelial ovarian cancer, including serous, mucinous, endo-
metroid and clear cell (Cancer and Steroid Hormone Study,
1987), and also in some benign lesions, such as
cystadenomas, follicular cysts and corpus luteum cysts
(Vessey et al., 1987).
The 200 patients included in this study represent 92% of
all cases diagnosed in Alberta between 1 January 1984 and
31 March 1986. Of the 18 patients excluded, nine had very
advanced disease at diagnosis and no interview could be
carried out and another nine refused to participate. Every
one of the 200 patients had their histological diagnosis
reviewed and confirmed by staff pathologists at the Cancer
Treatment Centers.
Each patient was interviewed personally and the
information obtained referred to date/place of birth,
occupational history, smoking, age at menarche, menstrual
characteristics, use of oral and other contraceptives, number
Table I Level of exposure
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of pregnancies, miscarriages and live births, age at
menopause, abdominal and pelvic surgery before the
diagnosis of ovarian cancer, use of talcum in the vaginal
area, height, weight and family history of cancer.
The patients were separated into four groups: adeno-
carcinoma (n=25), serous carcinomas (n=85), mucinous
carcinomas (n=22) and others (n =68). The first three
groups with well-defined histological types were then
compared by x2 and discriminant analysis in relation to risk
factors such as months on oral contraceptives, months on
other contraceptives, number of potentially fertile cycles,
number of pregnancies, parity, smoking habits, talcum
use, number of family members with cancer history and
years of education. The results of the analysis are shown in
Table I.
The different epithelial cancers seem to originate from cells
of the ovary surface that retain potentiality for differentia-
tion along Wolffian lines (Murphy & Beamer, 1980). There
may be some factors that influence the differentiation of the
cells with malignant potential and it may be useful to learn
more about these factors, since they may help to understand
better the mechanism of carcinogenesis.
This study only shows differences due to smoking habits,
but a larger number of patients and more detailed
information on other factors, such as diet, including coffee
and alcohol consumption, exposure to radiation or to virus
infection such as rubella or mumps, is needed to confirm
this.
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to risk factors in three different pathological diagnostic
groups of ovarian cancer
Age
Months on oral
contraceptives
Months on other
contraceptives
No. of fertile years
No. pregnancies
Weight (kg)
Percentage of
smokers
Percentage of
patients who
ever used
talcum powder
in perineum
Adenocarcinoma
(n =23)
64.6+ 10.4
16.6+28.8
Serous Mucinous
(n= 74) (n=21) P
60.5+11.9 56.1+13.5 n.s.
8.9+24.7 31.18+43.7 n.s.
108.0+111.3 115.8+130.0 110.2+119.1 n.s.
23.9+6.2 25.2+7.6 21.5+ 10.3 n.s.
3.5 +2.3
59.5+ 13.1
60
29
3.3+2.5 3.9+4.0 n.s.
67.9+ 14.5 65.6+ 12.8 n.s.
53
39
82 0.049
21 n.s.
The comparison was done by t test except for the last two items, done by x2.
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